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Peroxisomes contain a classical L-hydroxy-specific
peroxisome proliferator-inducible b-oxidation system
and also a second noninducible D-hydroxy-specific b-ox-
idation system. We previously generated mice lacking
fatty acyl-CoA oxidase (AOX), the first enzyme of the
L-hydroxy-specific classical b-oxidation system; these
AOX2/2 mice exhibited sustained activation of peroxi-
some proliferator-activated receptor a (PPARa), result-
ing in profound spontaneous peroxisome proliferation
in liver cells. These observations implied that AOX is
responsible for the metabolic degradation of PPARa li-
gands. In this study, the function of enoyl-CoA hy-
dratase/L-3-hydroxyacyl-CoA dehydrogenase (L-PBE),
the second enzyme of this peroxisomal b-oxidation sys-
tem, was investigated by disrupting its gene. Mutant
mice (L-PBE2/2) were viable and fertile and exhibited no
detectable gross phenotypic defects. L-PBE2/2 mice
showed no hepatic steatosis and manifested no sponta-
neous peroxisome proliferation, unlike that encoun-
tered in livers of mice deficient in AOX. These results
indicate that disruption of classical peroxisomal fatty
acid b-oxidation system distal to AOX step does not in-
terfere with the inactivation of endogenous ligands of
PPARa, further confirming that the AOX gene is indis-
pensable for the physiological regulation of this recep-
tor. The absence of appreciable changes in lipid metab-
olism also indicates that enoyl-CoAs, generated in the
classical system in L-PBE2/2 mice are diverted to D-hy-
droxy-specific system for metabolism by D-PBE. When
challenged with a peroxisome proliferator, L-PBE2/2
mice showed increases in the levels of hepatic mRNAs
and proteins that are regulated by PPARa except for
appreciable blunting of peroxisome proliferative re-
sponse as compared with that observed in hepatocytes
of wild type mice similarly treated. This blunting of
peroxisome proliferative response is attributed to the
absence of L-PBE protein in L-PBE2/2 mouse liver, be-
cause all other proteins are induced essentially to the
same extent in both wild type and L-PBE2/2 mice.
In animal cells, mitochondria, as well as peroxisomes, oxidize
fatty acids via b-oxidation, with long chain and very long chain
fatty acids being preferentially oxidized by peroxisomes (1–3).
Peroxisomal b-oxidation process is carried out by two distinct
groups of enzymes; the classical first group utilizes straight
chain saturated fatty acyl-CoAs as substrates, whereas the
recently discovered second group acts on branched chain acyl-
CoAs (3, 4). In the L-hydroxy-specific classical b-oxidation spi-
ral, dehydrogenation of acyl-CoA esters to their corresponding
trans-2-enoyl-CoAs is catalyzed by fatty acyl-CoA oxidase
(AOX),1 whereas the second and third reactions, hydration and
dehydrogenation of enoyl-CoA esters to 3-ketoacyl-CoA, are
carried out by a single enzyme, enoyl-CoA hydratase/L-3-hy-
droxyacyl-CoA dehydrogenase (L-bifunctional enzyme (L-PBE))
(3). The third enzyme of this classical system, 3-ketoacyl-CoA
thiolase (PTL) cleaves 3-ketoacyl-CoAs to acetyl-CoA, and an
acyl-CoA that is two carbon atoms shorter than the original
molecule can re-enter the b-oxidation spiral (1, 2). In the sec-
ond D-hydroxy-specific b-oxidation pathway, dehydrogenation
of acyl-CoA esters to their corresponding trans-2-enoyl-CoAs is
catalyzed by the branched chain acyl-CoA oxidase (2), with the
recently identified D-3-hydroxyacyl-CoA dehydratase/D-3-hy-
droxyacl-CoA dehydrogenase (D-bifunctional enzyme (D-PBE)),
converting enoyl-CoAs to 3-ketoacyl-CoAs via D-3-hydroxyacyl-
CoAs (3, 4). The third enzyme of this second system is desig-
nated as sterol carrier protein x (SCPx), which possesses 3-ke-
toacyl-CoA thiolase activity (5).
Of these two peroxisomal b-oxidation systems, the enzymes
belonging to the classical group are markedly induced in the
liver of rats and mice in conjunction with profound prolifera-
tion of peroxisomes by a group of structurally diverse agents
designated as peroxisome proliferators (6). They exert their
pleiotropic effects by activating a nuclear receptor called per-
oxisome proliferator-activated receptor a (PPARa) (7). Sus-
tained induction of PPARa-mediated peroxisome proliferation
and transcriptional activation of classical b-oxidation system
genes lead to the development of liver tumors in rats and mice
(8). It is postulated that H2O2 overproduced by the induction of
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this b-oxidation system and cell proliferation contribute to
hepatocarcinogenesis in livers with peroxisome proliferation (8,
9). To investigate the functional implications of PPARa-regu-
lated L-hydroxy-specific b-oxidation system, we recently gener-
ated mice deficient in AOX, the first enzyme of this inducible
system, and found that they exhibit steatohepatitis and spon-
taneous peroxisome proliferation in liver cells (10). These re-
sults suggested that straight chain acyl-CoAs and other puta-
tive substrates for classical AOX serve as natural ligands for
PPARa, and this enzyme is indispensable for the physiological
regulation of PPARa (10). Here, we describe the generation of
mice homozygous for a disruption of the L-PBE gene, which
encodes the second enzyme of this b-oxidation spiral and report
that these mice do not exhibit phenotypic alterations such as
those found in AOX null mice, further confirming that disrup-
tion of this classical b-oxidation pathway distal to AOX does
not affect the metabolism of natural ligands of PPARa.
MATERIALS AND METHODS
Gene Targeting—P1 genomic clone (6346) containing the L-PBE gene
was obtained by screening a mouse 129/Sv P1 bacteriophage library
(Genome Systems, St. Louis, MO) using polymerase chain reaction with
primers 59-GTGCTGATATCCATGGCTTTAGTG-39and 59-GATAGT-
GACAGCCCAAGGCCAGCTC-39 (11). The targeting construct was as-
sembled in the pPNT targeting vector with the 2.5-kb XbaI fragment
from the SacI subclone and 4-kb XbaI/ApaI fragment from the ApaI
subclone serving as the 59 and 39 homologous regions, respectively, of
the phosphoglycerate kinase promoter/neomycin-resistance gene (Neo)
(Fig. 1A). The targeting vector also contained the herpes simplex thy-
midine kinase (hsv-tk) gene, which allowed the use of a positive-nega-
tive selection scheme. The final construct, designated pPNT-L-PBE, is
illustrated in Fig. 1A.
Generation of L-PBE Mutant Mice—NotI-linearized targeting vector
(30 mg) was electroporated into BK4 embryonic stem (ES) cells and
selected in 200 mg/ml G418 and 2 mM ganciclovir, and resistant colonies
were subjected to Southern analysis. Two positive ES clones were
injected into 3.5-day-old C57BL/6J blastocysts and transferred into
pseudopregnant CBAF1 foster female recipients. The resulting chime-
ras were mated with C57BL/6J mice, and germ-line transmission was
ascertained by coat color and confirmed by Southern analysis of
genomic DNA (5 mg) isolated from tails, transferred to nitrocellulose
membrane, and hybridized with probe 1 and probe 2 (Fig. 1A) at 42 °C
in hybridization solution containing 50% formamide (12). F1 heterozy-
gous siblings for the disrupted PBE gene were then mated to obtain
homozygous PBE null mice.
Genotype of L-PBE Mutant Mice—The offspring from subsequent
breeding were genotyped by polymerase chain reaction amplification
and confirmed by Southern analysis as needed. Two primers, primers
P1 (59-GAGCTGGCCTTGGGCTGTCACTA-39) and P2 (59-TAGAAGCT-
GCGTTCCTCTTGCACCA-39), derived from exons 3 and 4 of L-PBE
gene, respectively, shown in Fig. 1A were designed to detect wild type
allele, and two primers, primers P3 (59-TGAATGAACTGCAGGAC-
GAGG-39) and P4 (59-CCACAGTCGATGAATCCAGAA-39), from the ne-
omycin cassette were used to detect the PBE gene-targeted allele.
Treatment with Peroxisome Proliferators and Morphological Stud-
ies—Mice were fed powdered diet with or without a PPARa ligand,
ciprofibrate (0.0125% w/w), or Wy-14,643 (0.1% w/w) for 4 to 14 days.
For light microscopy, tissues were fixed in 10% neutral-buffered forma-
lin and embedded in paraffin using standard procedures. Sections
(4-mm thick) were cut and stained with hematoxylin and eosin. For
cytochemical localization of catalase (CTL), tissues were processed and
examined as described elsewhere (10). Immunocytochemical localiza-
tion of CTL and L-PBE was performed using protein A-gold technique as
described elsewhere (13). To assess liver cell proliferation, some mice
were given bromodeoxyuridine (0.5 mg/ml) in drinking water for 3 days,
and their livers were processed for immunohistochemistry. AOX2/2
mice utilized in these studies were as described (10).
Western Blot Analysis and Fatty Acid Oxidation—Contents of b-ox-
idation enzymes and other proteins in liver were determined by immu-
noblot analysis using rabbit polyclonal antibodies against rat acyl-CoA
synthetase, AOX, L-PBE, D-PBE, PTL, carnitine octanoyltransferase,
urate oxidase, short chain acyl-CoA dehydrogenase, medium chain acyl-
CoA dehydrogenase, very long chain and long chain acyl-CoA dehydro-
genases (VLCAD and LCAD, respectively), SCPx, and CTL, as de-
scribed (14). Fatty acid b-oxidation activity was measured using
radioactive fatty acids (ICN Pharmaceuticals) and postnuclear fractions
from livers as described (14).
Northern Hybridization—Total RNA (20 mg) extracted from the liver
of wild type, L-PBE2/2, and AOX2/2 mice by Trizol reagent (Life Tech-
nologies, Inc.), was glyoxylated, separated on 0.8% agarose gel, and
transferred to nylon membrane. Hybridization was performed at 42 °C
in 50% formamide hybridization solution (12) using cDNA probes acyl-
CoA synthetase, AOX, L-PBE, D-PBE, PTL, cytochrome P450 v-hy-
droxylases (CYP4A1, CYP4A3), fatty acid-binding protein, and riboso-
mal RNA (28 S) as described (10). Changes in mRNA levels were
estimated by densitometric scanning of autoradiograms.
RESULTS
Generation of L-PBE2/2 Mice—The targeting construct illus-
trated in Fig. 1 was used to disrupt the L-PBE gene in ES cells.
Screening of 100 G418 ganciclovir-resistant colonies by South-
ern blotting yielded 5 homologous recombinants for a targeting
frequency of 5%. ES cells from two different colonies were
injected into C57BL/6J blastocysts to generate chimeric ani-
mals. Chimeras from both lines were able to transmit the
mutant allele to their offspring after outbreeding with C57BL/
6J. Genomic DNA from wild type mice when digested with
BamHI and EcoRI and probed with probe 1 yielded a single
4.3-kb fragment, and in L-PBE1/2 mouse DNA, two bands, 6.1
and 4.3 kb, were visualized (Fig. 1B). In L-PBE2/2 mice, there
is a single 6.1-kb band, indicating that both alleles were mod-
ified (Fig. 1B). At 2 weeks of age, the F1 progeny exhibited a
predicted frequency of 25% homozygous mutant offspring (L-
PBE2/2), indicating no lethality associated with the null allele.
L-PBE2/2 mice exhibited no growth retardation during the first
4 weeks and displayed no apparent morphological abnormali-
ties. Both male and female homozygous mice were fertile.
Northern blot analysis using poly(A)1 RNA isolated from liver
showed an absence of L-PBE mRNA in L-PBE2/2 mouse (Fig.
1C). Western blotting performed with anti-L-PBE antibody re-
vealed the presence of two bands close to each other in wild
type mouse liver (Fig. 1D). One of these proteins (the lower
band) was confirmed to be L-PBE, because it disappeared when
the antibodies were preincubated with purified rat L-PBE pro-
tein. The upper nonspecific band cross-reacting with anti-PBE
antibody is present in mitochondrial and not in peroxisomal
fraction (data not shown). In L-PBE2/2mouse liver, we also
detected this cross-reacting protein (upper band) but found no
authentic L-PBE protein. Immunohistochemically, L-PBE
staining appeared highly prominent in the liver of a wild type
mouse treated with a peroxisome proliferator for 2 weeks,
whereas no staining was evident in L-PBE2/2 mouse liver (Fig.
2). The absence of L-PBE protein in L-PBE2/2 mouse liver
peroxisomes was further confirmed at the ultrastructural level
by protein A-gold immunocytochemical procedure (Fig. 3).
Characterization of Liver Phenotype in L-PBE2/2 Mice and
Comparison with Mice Deficient in AOX—The histological ar-
chitecture of liver as well as the appearance of hepatocytes in
L-PBE2/2 mice did not differ significantly from that of wild type
animals (Fig. 4A and B). Of particular interest is that mice
deficient in L-PBE displayed no hepatic fatty metamorphosis, a
feature that is striking in young AOX deficient mice (Fig. 4C).
Progressive hepatocellular regeneration occurring in older
AOX2/2mice leads to the emergence of hepatocytes with abun-
dant eosinophilic cytoplasm suggestive of spontaneous peroxi-
some proliferation (Fig. 4, C and D). We then surveyed for
alterations, if any, in peroxisome population in liver cells of
L-PBE2/2 mice to ascertain if deficiency of this enzyme also
leads to spontaneous peroxisome proliferation such as that
encountered in AOX2/2 mice (10). Peroxisomes can be visual-
ized at the light microscopic level in sections processed cyto-
chemically for localizing peroxisomal marker enzyme catalase
(10). In L-PBE2/2 mouse hepatocytes, peroxisomes are few,
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randomly distributed in the cytoplasm, and appear as diami-
nobenzidine-positive brown granules (Fig. 4E). The numerical
density of these organelles in L-PBE2/2 mice on normal diet
appeared similar to that observed in wild type mice (Fig. 4F).
Thus, disruption of L-PBE gene fails to induce spontaneous
peroxisome proliferation such as that encountered in liver cells
of mice lacking AOX (Fig. 4, G and H).
Analysis of Fatty Acid-metabolizing Enzymes—The constitu-
tive and inducible levels of fatty acid-metabolizing enzymes in
livers of L-PBE2/2 and wild type mice were evaluated by im-
munoblotting. Constitutive levels of expression of several per-
oxisomal (AOX, PTL, D-PBE, carnitine octanoyltransferase,
SCPx, urate oxidase, and CTL) and mitochondrial (VLCAD,
LCAD, medium chain acyl-CoA dehydrogenase, and short
chain acyl-CoA dehydrogenase) enzymes were similar in wild
type and L-PBE2/2 mice (Fig. 5). The hepatic levels of AOX,
PTL, D-PBE, carnitine octanoyltransferase, LCAD, and me-
dium chain acyl-CoA dehydrogenase were increased in wild
type and L-PBE2/2 mice fed ciprofibrate for 2 weeks (Fig. 5). In
wild type mice treated with ciprofibrate, hepatic levels of L-
PBE protein increased substantially, and as expected, this
protein was not detected in L-PBE2/2mice maintained on con-
trol or ciprofibrate-containing diet (Fig. 5). These livers showed
the presence of a nonspecific, cross-reacting band described in
Fig. 1D, and this protein was not induced in L-PBE2/2 mice
treated with a peroxisome proliferator. Ciprofibrate did not
increase the levels of SCPx, CTL, VLCAD, and short chain
acyl-CoA dehydrogenase in wild type and L-PBE2/2 mouse
liver.
We also measured total hepatic b-oxidation using palmitic
acid in mice fed either a control or ciprofibrate-containing diet.
The basal level of total fatty acid b-oxidation was similar in
wild type and L-PBE2/2 mice. As expected, a 4- to 6-fold in-
FIG. 1. Generation of L-PBE-defi-
cient mice. A, schematic representation
of the mouse L-PBE gene, targeting vec-
tor, and structure of the locus following
gene targeting. Exons 2–5 (E2 to E5) in
the L-PBE gene are shown as closed boxes.
Restriction sites are indicated. Locations
of hybridization probes (probes 1 and 2)
used for Southern blot analysis and of
primers (P1 to P4) used for polymerase
chain reaction are shown. B, Southern
blot analysis of genomic DNA. Genomic
DNA (5 mg) isolated from tail tips of pups
was digested with BamHI and EcoRI and
hybridized with the 59-probe (probe 1
shown in A). Lanes: L-PBE1/1 wild type,
L-PBE1/2 heterozygous, L-PBE2/2 ho-
mozygous mice. C, Northern blot analysis
using poly(A1) RNA (5 mg/lane) isolated
from liver probed with L-PBE or b-actin
cDNA. D, Western blot analysis of liver
homogenates for L-PBE expression in wild
type (1/1) and L-PBE null (2/2) mice.
The antibodies recognize L-PBE (lower
band) and also an unidentified protein x
(upper band) in the wild type mice. In
L-PBE null mice only the upper band is
identifiable, but not the band represent-
ing L-PBE.
FIG. 2. Immunoperoxidase staining for L-PBE in the liver. Wild
type mouse (A) and L-PBE2/2 mice (B) were fed ciprofibrate (0.0125% in
diet) for 2 weeks, and sections of liver were processed for immunohis-
tochemical localization of L-PBE using antibodies against L-PBE. In-
tense cytoplasmic granular staining for L-PBE is seen in the liver of
wild type mouse but not in L-PBE2/2 mouse.
FIG. 3. Immunogold localization of catalase and L-PBE in liver
peroxisomes. A, catalase localization in L-PBE2/2 mouse liver. Note
the presence of gold particles (black dots) over peroxisome (p) matrix
representing catalase antigenic sites. B and C represent liver sections
from wild type mouse and L-PBE2/2 mouse, respectively, stained for
L-PBE. No gold particles are seen over peroxisomes (p) in L-PBE2/2
mouse liver.
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crease in total hepatic b-oxidation activity occurred in wild type
mice treated with ciprofibrate, and the response of L-PBE2/2
mice was essentially similar (data not presented). In contrast,
the ciprofibrate-induced increase in the activity of cyanide-
insensitive (peroxisomal) fatty acid b-oxidation system in
L-PBE2/2 mouse liver was ;75% that observed in wild type
mice treated with ciprofibrate (data not presented).
Induction of mRNAs—Constitutive levels of acyl-CoA syn-
thetase, AOX, PTL, CYP4A1, CYP4A3, D-PBE, and fatty acid-
binding protein mRNAs were similar in the livers of both wild
type and L-PBE2/2 mice, indicating that unlike in AOX2/2mice,
there is no spontaneous up-regulation of PPARa-regulated
genes in L-PBE2/2 mice (Fig. 6). Following treatment with
ciprofibrate, a 10-to 20-fold increase in liver AOX, PTL,
CYP4A1, and CYP4A3 mRNA levels occurred in both wild type
and L-PBE null mice, and the PTL, CYP4A1, and CYP4A3
increases were similar to spontaneous increases occurring in
AOX2/2mice (Fig. 6). Fig. 6 also confirms the expected absence
of AOX and L-PBE mRNAs in the livers of AOX2/2 and of
L-PBE2/2 mice, respectively. The spontaneous increase in L-
PBE mRNA in AOX2/2 mouse liver is comparable in magnitude
to that occurring in ciprofibrate-treated wild type mouse (Fig.
6). We also found ;5-fold increase in D-PBE mRNA level in the
liver of both wild type and L-PBE2/2 mice treated with
ciprofibrate.
Blunted Peroxisome Proliferative Response in L-PBE2/2
Mouse Liver—Rats and mice treated with peroxisome prolif-
erators such as ciprofibrate and Wy-14,643 exhibit abundant
peroxisome proliferation in hepatocytes with peroxisomes oc-
cupying ;20 to 25% of cytoplasmic volume (6, 8). In AOX2/2
mice we also found profound spontaneous proliferation of per-
oxisome, and such changes have been ascribed to sustained
activation of PPARa by endogenous ligands that require AOX
for metabolism or inactivation (10). We first established that
deficiency of L-PBE neither caused spontaneous peroxisome
proliferation nor led to an increase in protein and mRNA levels
of genes regulated by PPARa. We then evaluated the impact of
L-PBE gene disruption on peroxisome proliferation induced by
peroxisome proliferators (Fig. 7). Light microscopic analysis of
liver sections processed for cytochemical localization of catalase
revealed massive proliferation of peroxisomes in liver cells of
wild type mice treated with either ciprofibrate or Wy-14,643 for
2 weeks (Fig. 7A). In contrast, peroxisome-proliferative re-
sponse appeared blunted in L-PBE2/2 mouse liver (Fig. 7B).
These observations were confirmed at the ultrastructural level
in that peroxisome proliferation appeared robust in peroxisome
proliferator-treated wild type mice but subdued in L-PBE2/2
mouse liver cells (not illustrated). In L-PBE2/2 mice treated
with peroxisome proliferators, peroxisomal profiles tended to
be smaller than those seen in wild type liver. Analysis of liver
samples by SDS-polyacrylamide gel electrophoresis showed no
FIG. 4. Liver morphology and
changes in peroxisome population in
L-PBE2/2 and AOX2/2 mice. A-D, liver
sections stained with hematoxylin and eo-
sin. A, L-PBE2/2 mouse. B, wild type litter
mate. C, young AOX2/2 mouse with mi-
crovesicular fatty change and few regen-
erated hepatocytes (arrows) with abun-
dant eosinophilic cytoplasm, reflective of
spontaneous peroxisome proliferation
(see G below). D, older AOX2/2 mouse
liver with regenerated hepatocytes con-
taining granular eosinophilic cytoplasm
and scattered foamy lipid-laden macro-
phages (arrows). E–H, sections of liver
that were processed for the cytochemical
localization of peroxisomal catalase (11).
L-PBE null mouse liver (E) and wild type
mouse liver (F) show few peroxisomes in
hepatocytes (brown dots, arrows). G, liver
of a young AOX2/2 mouse with numerous
peroxisomes (arrows) in few liver cells
such as those depicted by arrows in C
above, whereas hepatocytes with microve-
sicular fatty change (Li) show few or no
detectable peroxisomes. H, in older
AOX2/2 mice, all regenerated liver cells
(see D above) show extensive spontaneous
peroxisome proliferation.
FIG. 5. Immunoblot analysis of selected fatty acid-metaboliz-
ing and other enzymes in liver. Liver homogenates from L-PBE2/2
and L-PBE1/1 mice fed either control or ciprofibrate (Cipro)-containing
diet were subjected to SDS-polyacrylamide gel electrophoresis and im-
munoblotting (3 mice each group). AOX (5 mg), L-PBE (10 mg; note only
the upper band, representing protein x, is present in L-PBE2/2 mouse
liver), PTL (10 mg); D-PBE (20 mg); SCPx (10 mg); carnitine octanoyl-
transferase (COT) (l0 mg); VLCAD (20 mg), LCAD (20 mg), medium
chain acyl-CoA dehydrogenase (MCAD) (20 mg); short chain acyl-CoA
dehydrogenase (SCAD) (10 mg); urate oxidase (UOX) (2 mg), and CTL (2
mg).
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increase in the 78-kilodalton L-PBE protein in L-PBE2/2 mice
treated with a peroxisome proliferator (Fig. 8).
Liver Cell Proliferation—Increased liver cell proliferation
has been noted in mice deficient in AOX 2/2, attributable in
part to cell loss resulting from extensive steatosis (10). Because
peroxisome proliferators are also known to induce transient
liver cell proliferation (8), we assessed the impact of L-PBE
gene disruption on hepatocyte proliferation induced by the
administration of a peroxisome proliferator in the diet for 3
days. No significant difference in hepatocyte nuclear labeling
was found between wild type and L-PBE2/2 mice treated with
a peroxisome proliferator (data not shown).
DISCUSSION
The classical peroxisome proliferator-inducible L-hydroxy-
specific peroxisomal b-oxidation system that acts on long and
very long straight chain acyl-CoAs, long chain dicarboxylyl-
CoAs, and the CoA esters of prostaglandins consists of AOX,
L-PBE, and PTL (2, 3). The second noninducible D-3-hydroxy-
specific peroxisomal b-oxidation system that acts on branch
chain acyl-CoAs also contains three enzymes namely, branched
chain acyl-CoA oxidase, D-PBE, and SCPx (3, 4, 15). Straight
chain acyl-CoAs are almost exclusively metabolized by classical
AOX and not by D-hydroxy-specific branched chain acyl-CoA
oxidase, although the enzymes of D-hydroxy-specific b-oxida-
tion pathway reveal minor catalytic activity toward straight
chain acyl-CoAs (3, 4, 15). This assumption is supported by the
observations in mice deficient in classical AOX as they exhibit
sustained up-regulation of PPARa-induced genes along with
spontaneous peroxisome proliferation in liver parenchymal
cells, indicating that this L-hydroxy-specific AOX is crucial for
metabolically degrading biological ligands of PPARa (10, 16).
Because this classical b-oxidation system degrades long and
very long straight chain fatty acids, long chain dicarboxylic
acids, and prostaglandins or their respective CoAs, it is reason-
able to conclude that these and possibly other yet to be identi-
fied substrates of L-hydroxy-specific AOX act as natural ligands
of PPARa (10). These AOX-deficient mice also highlight the
fact that substrates of this classical AOX that function as
PPARa ligands are not degraded by D-hydroxy-specific
branched chain acyl-CoA oxidase. Here we have described the
generation and initial characterization of a mouse homozygous
for a targeted disruption of L-PBE, the enzyme immediately
distal to AOX in the classical L-hydroxy-specific b-oxidation
pathway. L-PBE2/2mice, in combination with AOX2/2 (10),
PPARa2/2 (17), X-ALD2/2 (X-linked adrenoleukodystrophy
FIG. 9. Schematic representation of peroxisome proliferator
inducible, L-hydroxy-specific, classical peroxisomal b-oxidation
system and the noninducible D-hydroxy-specific system. In mice
deficient in L-PBE, the straight chain enoyl-CoAs are most likely di-
verted to the noninducible branched chain b-oxidation pathway for
metabolism by D-PBE. In contrast, in AOX2/2 mice, the straight chain
fatty acyl-CoAs and possibly other PPARa ligands are not metabolized
because of the absence of AOX, and these substrates are not diverted to
a noninducible system for degradation by branched chain acyl-CoA
oxidase, thus causing sustained activation of PPARa.
FIG. 6. Northern blot analysis of total RNA extracted from
liver. Total RNA (20 mg) from L-PBE2/2 and wild type littermate mice
on control (2) or ciprofibrate (Cipro, 0.0125% w/w)-containing diet (1)
for 2 weeks was hybridized with 32P-labeled cDNA probes as indicated.
Liver RNA from 6-month-old AOX null mice on control diet is used for
comparison to show spontaneous up-regulation of PPARa-controlled
genes in AOX2/2 mouse liver. Acyl-CoA synthetase (ACS), AOX, L-PBE,
PTL, CYP4A1, CYP4A3, D-PBE, and fatty acid-binding protein (FABP)
genes are transcriptionally activated by PPARa. D-PBE mRNA is also
increased but to a lesser extent than that of L-PBE in wild type mice fed
ciprofibrate. 28 S RNA is used as loading indicator.
FIG. 7. Response of PBE2/2 and wild type littermate mice to a
peroxisome proliferator. Ciprofibrate, a peroxisome proliferator,
was fed in the diet for 2 weeks (0.0125% w/w). Livers were processed for
cytochemical localization of peroxisomal catalase. L-PBE 2/2 (A) and
wild type mice (B) were treated with ciprofibrate. Peroxisomes appear
as black dots in these black and white photographs; in L-PBE2/2 mouse
liver, ciprofibrate-induced peroxisome proliferation is somewhat
subdued.
FIG. 8. SDS-polyacrylamide gel electrophoresis of liver homo-
genates. Liver samples from wild type and L-PBE2/2 mice fed control
diet (2) or a diet containing Wy-14,643 (1) were subjected to SDS-
polyacrylamide gel electrophoresis, and the gel was stained with Coo-
massie Brilliant R Blue. Note the presence of massive amounts of
78-kDa L-PBE protein in the liver of wild type mouse treated with
Wy-14,643 (arrow); it is not present in L-PBE2/2mice.
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gene (18)), SCPx 2/2 (19), LCAD2/2 (20) and other mouse
models should prove valuable in exploring the functional role
and/or redundancy of metabolic pathways in lipid metabolism.
These mutant mice will also be valuable in investigating the
role of the enzymes of lipid metabolism in regulating the func-
tion of PPARa and possibly other receptors (10, 20).
There are several lines of evidence that support the view that
the mice we generated in this study contain a null mutation in
the L-PBE gene. The gene targeting construct we used was
designed to eliminate the entire exon 4, and the selectable gene
cassette used to disrupt the L-PBE gene introduced nonsense
mutation in all reading frames. Polymerase chain reaction as
well as Southern blot analysis revealed that ES cells contained
the correct targeted event, and Northern blot analysis revealed
that liver from L-PBE2/2 mice fed either a control diet or
peroxisome proliferator-containing diet did not contain a de-
tectable message corresponding to the L-PBE probe. The
L-PBE2/2 mice displayed no authentic L-PBE protein on West-
ern blot analysis; the L-PBE antibody we used was raised
against rat L-PBE, and in mouse liver, it recognized a nonspe-
cific protein band, designated protein x, the identity of which,
however, remains to be determined (Fig. 1D). By immunogold
technique, this protein x was detected in mitochondria and not
in peroxisomes of L-PBE2/2mice, further confirming the L-PBE
null mutation. It is also worth noting that this protein x was
not induced in the livers of wild type and L-PBE2/2 mice
treated with peroxisome proliferators. Peroxisome of
L-PBE2/2 mice did not reveal any staining for L-PBE by im-
munogold procedure (Fig. 3C), and when these animals were
treated with a peroxisome proliferator, the liver parenchymal
cells failed to show any immunohistochemically detectable L-
PBE protein (Fig. 2). These observations unequivocally estab-
lish the disruption of L-PBE gene, and the absence of L-PBE
mRNA and protein, therefore, establish the functional inacti-
vation of this gene.
The striking results observed in these L-PBE2/2 mice were
the absence of hepatic steatosis and of spontaneous peroxisome
proliferation such as that found in the livers of young AOX2/2
mice (10). These observations provide strong evidence that the
classical AOX of the L-hydroxy-specific b-oxidation system is
responsible for the metabolism of all putative ligands of PPARa
and that L-PBE enzyme immediately downstream of AOX is not
essential for the successful completion of the L-hydroxy-specific
b-oxidation. It would appear that once the long and very long
straight chain acyl-CoAs, long chain dicarboxylyl-CoAs, and
the CoA esters of prostaglandins are converted into their re-
spective enoyl-CoAs by the classical AOX, these can be metab-
olized by D-PBE of the D-hydroxy-specific peroxisomal b-oxida-
tion system (Fig. 9) or even by the mitochondrial b-oxidations
system. In essence, the AOX null and L-PBE null mouse models
we generated convincingly prove that classical AOX is pivotal
for the metabolic degradation of PPARa ligands and not the
branched chain acyl-CoA oxidase of the second system. Further
studies, however, are needed to rule out the possibility that
straight chain enoyl-CoAs generated by classical AOX, if left
unmetabolized, serve as PPARa ligands (10, 21). This issue can
be explored by generating mice deficient in both L-PBE and
D-PBE and characterizing their liver phenotype.
Of further interest is that L-PBE2/2 mice, when challenged
with a peroxisome proliferator, exhibited somewhat blunted
hepatic peroxisome proliferative response, although there were
no significant differences in other immediate or early pleiotro-
pic responses attributable to PPARa activation, with the single
notable, but expected exception that L-PBE mRNA and protein
are undetectable in L-PBE2/2 mouse livers. Thus, the blunting
of peroxisome proliferative response is attributed to the ab-
sence of L-PBE protein in L-PBE null animals. It is important to
note that L-PBE, a 78-kilodalton protein, is massively induced
in the livers of wild type mice exposed to peroxisome prolifera-
tors (22). This protein, once called peroxisome proliferator-
activated polypeptide (22), becomes the most abundant protein
in the livers of peroxisome proliferator-treated rats and mice,
contributing substantially to the morphological phenomenon of
peroxisome proliferation. The L-PBE null mutation abolishes
the inducibility of L-PBE in response to peroxisome prolifera-
tors, and this most likely accounts for the blunting of peroxi-
some proliferative response, because all other PPARa respon-
sive genes in L-PBE2/2mice are up-regulated. Therefore, it is
conceivable that changes in the levels of expression of L-PBE
gene in nonrodent species in response to peroxisome prolifera-
tors may influence the morphological phenomenon of peroxi-
some proliferation, whereas other effects of these PPARa li-
gands in nonrodent species may be similar to those seen in rats
and mice. It would be of great interest to investigate whether
L-PBE2/2mice develop liver tumors following chronic exposure
to peroxisome proliferators, despite the subdued nature of per-
oxisome proliferative response, because all other PPARa-regu-
lated genes are up-regulated.
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